InSightec ExAblate Panel To Consider International Uterine Fibroid Data
InSightec's PMA for non-invasive ExAblate 2000 treatment of uterine fibroids will be reviewed by FDA's Obstetrics & Gynecology Devices Panel June 3
InSightec's PMA for non-invasive ExAblate 2000 treatment of uterine fibroids will be reviewed by FDA's Obstetrics & Gynecology Devices Panel June 3